General Archives - Page 2359 of 2367

1 minute read

Which Former Disney Channel Actor Is Now Baring All With An OnlyFans Page?

July 6, 11:03 AM

Dan Benson, a former child star on the Walt Disney Co.’s (NYSE: DIS) cable television Disney Channel, has re-emerged as a clothing-free presence on the OnlyFans platform.

DIS

1 minute read

Asked If He Will Be PM Tomorrow, UK PM Johnson Says ‘Of Course’

By Benzinga Newsdesk

July 6, 10:51 AM

-Reuters

EWU

1 minute read

T2 Biosystems Shares Slide As Interim Q2 Sales Trail Consensus

By Vandana Singh

July 6, 10:21 AM

T2 Biosystems Inc (NASDAQ:TTOO) expects Q2 FY22 revenues of $5.8 million – $6.1 million, below the consensus of $6.87 million.…

TTOO

1 minute read

General

‘Toyota runs out of federal EV tax credits, pushing prices higher’ -Engadget

By Bill Haddad

July 6, 10:15 AM

https://twitter.com/engadget/status/1544685611780657157

1 minute read

Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial

By Vandana Singh

July 6, 9:55 AM

Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new functional data across multiple studies from the SRP-9001 (delandistrogene moxeparvovec) program for Duchenne muscular dystrophy. …

RHHBF

1 minute read

General

REV Group’s ENC Delivers Fleet Of E-Z Rider II Buses To San Francisco Municipal Transportation Agency

By Bill Haddad

July 6, 9:52 AM

https://revgroup.com/enc-delivers-fleet-of-e-z-rider-ii-hybrid-electric-buses-to-san-francisco-municipal-transportation-agency/

REVG

1 minute read

WHO Says More Than 6,000 Cases Of Monkeypox Reported From 58 Countries, Will Reconvene Emergency Committee Week Of 18 July Or Sooner

By Bill Haddad

July 6, 9:40 AM

-Reuters

AEMD

1 minute read

Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants

By Vandana Singh

July 6, 9:28 AM

Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing. IMM-BCP-01…

IMNM

3 minute read

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate

By Vandana Singh

July 6, 9:14 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AMTI

1 minute read

InflaRx’s Stock Gains Following FDA Fast Track Status To Skin Disease Drug

By Ragothaman Srinivasan

July 6, 8:53 AM

The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).

IFRX